Exhibit 23.1


Consent of Independent Registered Public Accounting Firm


The Board of Directors

Sonnet BioTherapeutics Holdings, Inc.:


We consent to the use of our report dated December 15, 2022, with respect to the consolidated financial statements of Sonnet BioTherapeutics Holdings, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.




Philadelphia, Pennsylvania

January 30, 2023